These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 3118267

  • 1. Polyacrylonitrile complement activation attenuated by simultaneous ultrafiltration and adsorption.
    Röckel A, Hertel J, Perschel WT, Walb D, Fiegel P, Panitz N, Abdelhamid S.
    Nephrol Dial Transplant; 1987; 2(4):251-3. PubMed ID: 3118267
    [Abstract] [Full Text] [Related]

  • 2. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D.
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [Abstract] [Full Text] [Related]

  • 3. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
    Schifferli JA, Steiger G, Paccaud JP.
    Clin Exp Immunol; 1986 May; 64(2):407-14. PubMed ID: 3488858
    [Abstract] [Full Text] [Related]

  • 4. Complement activation and hypersensitivity reactions to dialysis membranes.
    Hakim RM, Breillatt J, Lazarus JM, Port FK.
    N Engl J Med; 1984 Oct 04; 311(14):878-82. PubMed ID: 6332276
    [Abstract] [Full Text] [Related]

  • 5. Anaphylatoxin levels in human aqueous humor.
    Mondino BJ, Sumner H.
    Invest Ophthalmol Vis Sci; 1986 Aug 04; 27(8):1288-92. PubMed ID: 3488296
    [Abstract] [Full Text] [Related]

  • 6. Leucopenia, hypoxia and complement activation in haemodialysis. Three unrelated phenomena.
    de Vinuesa SG, Resano M, Luño J, Gonzalez C, Barril G, Junco E, Valderrabano F.
    Proc Eur Dial Transplant Assoc; 1983 Aug 04; 19():159-67. PubMed ID: 6878230
    [Abstract] [Full Text] [Related]

  • 7. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.
    Chenoweth DE, Cheung AK, Henderson LW.
    Kidney Int; 1983 Dec 04; 24(6):764-9. PubMed ID: 6609269
    [Abstract] [Full Text] [Related]

  • 8. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
    Langone JJ, Das C, Bennett D, Terman DS.
    J Immunol; 1984 Aug 04; 133(2):1057-63. PubMed ID: 6610702
    [Abstract] [Full Text] [Related]

  • 9. Is the dialysate fluid source of complement activating factors?
    Minetti L, Broggi ML, Civati G, Guastoni C, Teatini U.
    Trans Am Soc Artif Intern Organs; 1985 Aug 04; 31():673-7. PubMed ID: 3879782
    [Abstract] [Full Text] [Related]

  • 10. Complement activation produced by biomaterials.
    Chenoweth DE.
    ASAIO Trans; 1986 Aug 04; 32(1):226-32. PubMed ID: 3490860
    [No Abstract] [Full Text] [Related]

  • 11. C3, C5 components and C3a, C4a, and C5a fragments of the complement system.
    Janatova J.
    Methods Enzymol; 1988 Aug 04; 162():579-625. PubMed ID: 3265757
    [No Abstract] [Full Text] [Related]

  • 12. Anaphylatoxin levels in human vitreous humor.
    Mondino BJ, Sidikaro Y, Sumner H.
    Invest Ophthalmol Vis Sci; 1988 Jul 04; 29(7):1195-8. PubMed ID: 3262096
    [Abstract] [Full Text] [Related]

  • 13. Activation of human serum complement with allergens. I. Generation of C3a, C4a, and C5a and induction of human neutrophil aggregation.
    Nagata S, Glovsky MM.
    J Allergy Clin Immunol; 1987 Jul 04; 80(1):24-32. PubMed ID: 3496373
    [Abstract] [Full Text] [Related]

  • 14. Complement C3 and C5 degradation products during hemodialysis treatment: study of an index of membrane bioincompatibility.
    Freyria AM, Leitienne P, Veysseyre CN, Bringuier JP, Traeger J.
    Int J Artif Organs; 1988 Mar 04; 11(2):111-8. PubMed ID: 3259552
    [Abstract] [Full Text] [Related]

  • 15. Anaphylatoxins C3a and C5a adsorption on acrylonitrile membrane of hollow-fiber and plate dialyzer--an in vivo study.
    Kandus A, Ponikvar R, Drinovec J, Kladnik S, Ivanovich P.
    Int J Artif Organs; 1990 Mar 04; 13(3):176-80. PubMed ID: 2347666
    [Abstract] [Full Text] [Related]

  • 16. Plasma lactoferrin reflects granulocyte activation via complement in burn patients.
    Wolach B, Coates TD, Hugli TE, Baehner RL, Boxer LA.
    J Lab Clin Med; 1984 Feb 04; 103(2):284-93. PubMed ID: 6607301
    [Abstract] [Full Text] [Related]

  • 17. Complement activation in patients with primary antiphospholipid syndrome.
    Oku K, Atsumi T, Bohgaki M, Amengual O, Kataoka H, Horita T, Yasuda S, Koike T.
    Ann Rheum Dis; 2009 Jun 04; 68(6):1030-5. PubMed ID: 18625630
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms and kinetics of the synthesis and release of platelet-activating factor (PAF) by polyacrylonitrile membranes.
    Guastoni C, Tetta C, Hoenich NA, Gervasio R, Sereni L, Tessore E, Wratten ML, Civati G.
    Clin Nephrol; 1996 Aug 04; 46(2):132-8. PubMed ID: 8869791
    [Abstract] [Full Text] [Related]

  • 19. Serum complement levels and severity of sepsis.
    Nakae H, Endo S, Inada K, Takakuwa T, Kasai T, Yoshida M.
    Res Commun Chem Pathol Pharmacol; 1994 May 04; 84(2):189-95. PubMed ID: 8091004
    [Abstract] [Full Text] [Related]

  • 20. Complement activation and neutrophil aggregation changes during haemodialysis.
    Kubatiev A, Rudko I, Ermolenko V.
    Int J Clin Pharmacol Res; 1993 May 04; 13(6):293-9. PubMed ID: 8088929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.